Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTO60BY)

DTT Name microRNA hsa-miR-29b (MIR29b)
Gene Name MIR29b
DTT Type
Clinical trial target
 [1]
BioChemical Class
Non-coding RNA target
UniProt ID
NOUNIPROTAC
TTD ID
T41202

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Remlarsen DM2USXP Keloid EE60 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 miR-29b contributes to multiple types of muscle atrophy. Nat Commun. 2017 May 25;8:15201.
2 A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin. J Invest Dermatol. 2019 May;139(5):1073-1081.